Labisan
FDA Label NDC 72892-932

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Labisan Americas, Llc. for the product Labisan (NDC 72892-932). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, inactive ingredients, keep out of reach children, stop using and consult a doctor if the condition persists or gets worse. do not use longer than 2 weeks unless directed by a doctor., warnings, directions, uses, precautions allergy alert. when using product, stop and consult physician,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.